Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

September 01, 2007 (Vol. 27, No. 15)

Accelerator MS Is a Powerful New Tool

Technology Has Broad Applicability in Biomedical Research

  • To meet investor expectations and to achieve annual growth rates of 10%, each major pharma company must launch four new chemical entities (NCEs) per year, each with average annual sales of $350 million. However, the industry launches fewer than one NCE per year per company, and only a quarter ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.